首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1800211

全球重症加護診斷市場：2025 年至 2030 年預測

Global Critical Care Diagnostics Market - Forecasts fom 2025 to 2030

出版日期: 2025年08月07日 | 出版商:

Knowledge Sourcing Intelligence | 英文 151 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

重症加護診斷市場預計將從 2025 年的 1,665,035,000 美元成長到 2030 年的 2,244,484,000 美元，複合年成長率為 6.15%。

預計重症加護診斷市場將在2025年至2030年間強勁成長，這得益於嚴重和末期病患對快速精準診斷解決方案日益成長的需求。這些診斷包括癌症生物標記篩檢、心臟標記診斷、藥物濫用檢測、病原體篩檢和膽固醇檢測等，使醫生能夠快速診斷疾病並及時啟動治療。儘管慢性病盛行率上升和先進診斷技術日益普及推動了市場的發展，但設備成本上升和熟練專業人員短缺等挑戰可能阻礙市場的發展。

市場促進因素

重症加護診斷市場受慢性疾病（尤其是心臟疾病和癌症）盛行率上升的驅動。這些疾病的全球負擔推動了對能夠提供快速準確結果的檢測的需求，使醫生能夠及時做出明智的治療決策。此外，醫療保健專業人員擴大採用重症加護診斷也是一個主要的成長要素。這些診斷由侵入式和非侵入式監測設備支持，在加護治療環境中變得越來越重要，因為準確性和速度至關重要。診斷平台的技術進步進一步提高了可靠性和可近性，從而進一步推動了市場擴張。

市場限制

儘管重症加護診斷市場擁有成長潛力，但也面臨顯著挑戰。分子檢測平台和影像系統等先進診斷設備價格高昂，可能會限制其普及，尤其是在資源匱乏的醫療環境中。此外，缺乏熟練操作複雜診斷系統和解讀結果的專業人員，也構成了重大障礙，尤其是在開發中地區。除非透過經濟高效的創新和強化培訓項目來解決這些限制因素，否則市場成長可能會受到阻礙。

介紹
北美洲
- 按類型
- 按用途
- 按國家
  - 美國
  - 加拿大
  - 墨西哥
南美洲
- 按類型
- 按用途
- 按國家
  - 巴西
  - 阿根廷
  - 其他
歐洲
- 按類型
- 按用途
- 按國家
  - 德國
  - 法國
  - 英國
  - 西班牙
  - 其他
中東和非洲
- 按類型
- 按用途
- 按國家
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 以色列
  - 其他
亞太地區
- 按類型
- 按用途
- 按國家
  - 中國
  - 印度
  - 日本
  - 韓國
  - 印尼
  - 泰國
  - 其他

第8章競爭格局及分析

主要企業和策略分析
市場佔有率分析
合併、收購、協議和合作
競爭對手儀表板

第9章：公司簡介

Abbott Laboratories
bioMerieux SA
Danaher Corporation
Radiometer Medical ApS
Trivitron Healthcare
Siemens Healthcare GmbH
Becton Dickinson Company
Bayer AG
Roche Diagnostics
Bio-Rad Laboratories, Inc.

第10章附錄

貨幣
先決條件
基準年和預測年時間表
相關人員的主要利益
調查方法
簡稱

簡介目錄

Product Code: KSI061611691

The global critical care diagnostics market is expected to grow from USD1,665.035 million in 2025 to USD2,244.484 million in 2030, at a CAGR of 6.15%.

The critical care diagnostics market is poised for robust growth from 2025 to 2030, driven by the increasing need for rapid and accurate diagnostic solutions for critically ill or terminally ill patients with life-threatening conditions. These diagnostics, encompassing tests such as cancer biomarker screening, cardiac marker diagnostics, drug abuse testing, pathogen screening, and cholesterol testing, enable physicians to diagnose diseases swiftly and initiate timely treatment. The market is propelled by the rising prevalence of chronic diseases and the growing adoption of advanced diagnostic technologies, though challenges like high equipment costs and a shortage of skilled professionals may impede progress.

Market Drivers

The critical care diagnostics market is primarily driven by the rising incidence of chronic diseases, notably cardiac conditions and cancer, which require sophisticated diagnostic tools for effective management. The global burden of these diseases has increased demand for tests that provide rapid and precise results, enabling physicians to make informed treatment decisions without delay. Additionally, the growing adoption of critical care diagnostics by healthcare professionals is a significant growth factor. These diagnostics, supported by invasive and non-invasive monitoring devices, are increasingly integral to intensive care settings, where accuracy and speed are paramount. Technological advancements in diagnostic platforms further enhance their reliability and accessibility, boosting market expansion.

Market Restraints

Despite its growth potential, the critical care diagnostics market faces notable challenges. The high cost of advanced diagnostic equipment, such as molecular testing platforms and imaging systems, can limit adoption, particularly in resource-constrained healthcare settings. Additionally, a shortage of skilled professionals trained to operate complex diagnostic systems and interpret results poses a significant barrier, especially in developing regions. These constraints may hinder market growth unless addressed through cost-effective innovations and enhanced training programs.

Market Segmentation

By Application

The critical care diagnostics market is segmented into hematology, cardiac and lipid testing, coagulation testing, microbial and infectious disease testing, and others. Cardiac and lipid testing holds a significant share due to the high prevalence of cardiovascular diseases, necessitating rapid biomarker diagnostics. Microbial and infectious disease testing is also growing, driven by the need for early detection of pathogens in critical care settings. Hematology and coagulation testing remain vital for managing blood-related disorders, while other applications, such as cancer biomarker testing, are gaining traction due to rising cancer rates.

By End Users

The market is segmented into diagnostic centers, research laboratories, home care settings, and others. Diagnostic centers dominate due to their advanced infrastructure and capacity to handle high-throughput testing for critically ill patients. Research laboratories contribute to market growth through the development of novel diagnostic technologies. Home care settings are emerging as a growing segment, driven by the increasing availability of portable diagnostic devices, which enable monitoring and testing outside traditional healthcare facilities.

By Geography

The global critical care diagnostics market is segmented into North America, South America, Europe, the Middle East and Africa (MEA), and Asia-Pacific. North America leads due to its advanced healthcare infrastructure, high adoption of cutting-edge diagnostics, and significant prevalence of chronic diseases. Europe follows closely, supported by robust research and development activities. The Asia-Pacific region is expected to witness rapid growth, driven by increasing healthcare investments and rising disease burdens in countries like China and India. South America and MEA are also projected to grow, supported by improving healthcare access and awareness.

Key Industry Players

Major players in the critical care diagnostics market include companies focused on developing innovative diagnostic solutions. These players are investing in research, strategic partnerships, and product launches to strengthen their market positions. The report highlights their competitive strategies, financial performance, and recent developments, emphasizing their role in advancing diagnostic technologies.

The critical care diagnostics market is set for significant growth from 2025 to 2030, driven by the rising prevalence of chronic diseases and the adoption of advanced diagnostic tools. While high costs and a shortage of skilled professionals present challenges, the market's outlook remains positive, particularly in North America, Europe, and Asia-Pacific. Industry players must focus on affordability, training, and technological innovation to capitalize on the growing demand for rapid and accurate diagnostics in critical care settings.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2020 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Global Critical Care Diagnostics Market Segmentation

By Type

Haematology
Cardiac and Lipid Testing
Coagulation Testing
Microbial and Infectious Disease Testing
Others

By End-User

Hospitals
Diagnostics Centers
Home Care Setting
Others

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY TYPE

5.1. Introduction
5.2. Haematology
5.3. Cardiac and lipid Testing
5.4. Coagulation Testing
5.5. Microbial and Infectious Disease Testing
5.6. Others

6. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY END-USER

6.1. Introduction
6.2. Hospitals
6.3. Diagnostics Centers
6.4. Home Care Settings
6.5. Others

7. GLOBAL CRITICAL CARE DIAGNOSTICS MARKET BY GEOGRAPHY

7.1. Introduction
7.2. North America
- 7.2.1. ByType
- 7.2.2. By Application
- 7.2.3. By Country
  - 7.2.3.1. USA
  - 7.2.3.2. Canada
  - 7.2.3.3. Mexico
7.3. South America
- 7.3.1. By Type
- 7.3.2. By Application
- 7.3.3. By Country
  - 7.3.3.1. Brazil
  - 7.3.3.2. Argentina
  - 7.3.3.3. Others
7.4. Europe
- 7.4.1. By Type
- 7.4.2. By Application
- 7.4.3. By Country
  - 7.4.3.1. Germany
  - 7.4.3.2. France
  - 7.4.3.3. United Kingdom
  - 7.4.3.4. Spain
  - 7.4.3.5. Others
7.5. Middle East and Africa
- 7.5.1. By Type
- 7.5.2. By Application
- 7.5.3. By Country
  - 7.5.3.1. Saudi Arabia
  - 7.5.3.2. UAE
  - 7.5.3.3. Israel
  - 7.5.3.4. Others
7.6. Asia Pacific
- 7.6.1. By Type
- 7.6.2. By Application
- 7.6.3. By Country
  - 7.6.3.1. China
  - 7.6.3.2. India
  - 7.6.3.3. Japan
  - 7.6.3.4. South Korea
  - 7.6.3.5. Indonesia
  - 7.6.3.6. Thailand
  - 7.6.3.7. Others